Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 155, Issue 2, Pages 137-149Publisher
WILEY
DOI: 10.1111/j.1365-2141.2011.08826.x
Keywords
obesity; drug dosing; anticoagulants; venous thromboembolism; acute coronary syndromes
Categories
Funding
- Guy's and St Thomas'/King's College London NIHR comprehensive Biomedical Research Centre
Ask authors/readers for more resources
The prevalence of obesity has increased substantially over recent years. Clinicians are increasingly being challenged with making uncertain anticoagulant dosing decisions, as the optimal dosing strategy for most anticoagulants in the obese patient population remains unknown. Research published to date suggests that the clearance of anticoagulants increases with weight. As obesity is associated with an increased risk of venous thromboembolism and arterial disease, there is an urgent need to establish appropriate anticoagulation regimens for this patient group. Research studies applying the method of pharmacokinetic-pharmacodynamic modelling and simulation could establish an appropriate evidence base and provide direction and reassurance to prescribing clinicians.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available